Double-blind randomized parallel intergroup trial about the efficacy of the immobilized antibacterial ingredient Etak processing shirt for atopic dermatitis

Double-blind randomized parallel intergroup trial about the efficacy of the immobilized antibacterial ingredient Etak processing shirt for atopic dermatitis - Double-blind randomized parallel intergroup trial about the efficacy of the immobilized antibacterial ingredient Etak processing shirt for atopic dermatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023390

Enrollment

Registered

2016-07-29

Start date

2016-07-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

the immobilized antibacterial ingredient Etak processing shirt Shirt roughness

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age at agreement acquisition is the patient 70 years or younger 16 years old or older The patients with atopic dermatitis (the patients that a rank of the steroid medicine for external application prescribed for one month does not have a change) who are stable in their symptom for one month The patients that there is not serious underlying disease such as the serious heart disorder, and the overall status is stable The patients that an agreement is obtained in a document from the person about participation of this study

Exclusion criteria

Exclusion criteria: The patients who receive steroid internal use therapy, cyclosporine internal use therapy The patients in the physique part without a symptom of atopic dermatitis The patients whom the shirt is not their size The patients who admitted that it was inadequate so that a study person in charge or a study partaker underwent this study

Design outcomes

Primary

Measure	Time frame
SCORAD	—

Countries

Japan

Contacts

Public ContactTomofumi Numata

Hiroshima University, Hiroshima, Japan Department of Dermatology,

t_numa_925@yahoo.co.jp082-257-5238

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026